Log In
BCIQ
Print this Print this
 

AVX901

  Manage Alerts
Collapse Summary General Information
Company AlphaVax Inc.
DescriptionHER2-expressing virus-like replicon particle (VRP) vaccine
Molecular Target Epidermal growth factor receptor 2 (HER2) (EGFR2) (ErbB2) (neu)
Mechanism of ActionEpidermal growth factor (EGF) receptor 2 (HER2) (ErbB2) (neu) inhibitor
Therapeutic ModalityPreventive vaccine: Viral vaccine
Latest Stage of DevelopmentPhase I
Standard IndicationBreast cancer
Indication DetailsTreat late-stage HER2-expressing breast cancer
Regulatory Designation
Partner

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today